Shandong Pharmaceutical Glass Co.Ltd

SHSE:600529 Rapporto sulle azioni

Cap. di mercato: CN¥16.6b

Shandong Pharmaceutical GlassLtd Performance dei guadagni passati

Il passato criteri di controllo 5/6

Shandong Pharmaceutical GlassLtd has been growing earnings at an average annual rate of 12.3%, while the Medical Equipment industry saw earnings growing at 6.4% annually. Revenues have been growing at an average rate of 12.1% per year. Shandong Pharmaceutical GlassLtd's return on equity is 11.3%, and it has net margins of 17.2%.

Informazioni chiave

12.3%

Tasso di crescita degli utili

9.6%

Tasso di crescita dell'EPS

Medical Equipment Crescita del settore16.0%
Tasso di crescita dei ricavi12.1%
Rendimento del capitale proprio11.3%
Margine netto17.2%
Ultimo aggiornamento sui guadagni30 Sep 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Returns On Capital At Shandong Pharmaceutical GlassLtd (SHSE:600529) Have Hit The Brakes

Aug 25
Returns On Capital At Shandong Pharmaceutical GlassLtd (SHSE:600529) Have Hit The Brakes

Calculating The Fair Value Of Shandong Pharmaceutical Glass Co.Ltd (SHSE:600529)

May 31
Calculating The Fair Value Of Shandong Pharmaceutical Glass Co.Ltd (SHSE:600529)

The Returns At Shandong Pharmaceutical GlassLtd (SHSE:600529) Aren't Growing

May 13
The Returns At Shandong Pharmaceutical GlassLtd (SHSE:600529) Aren't Growing

Shandong Pharmaceutical Glass Co.Ltd Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next

Apr 26
Shandong Pharmaceutical Glass Co.Ltd Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next

Ripartizione dei ricavi e delle spese

Come Shandong Pharmaceutical GlassLtd guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

SHSE:600529 Ricavi, spese e utili (CNY Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Sep 245,133882362160
30 Jun 245,146865370153
31 Mar 245,013830366147
31 Dec 234,982776344138
30 Sep 234,872738292128
30 Jun 234,633682285132
31 Mar 234,382632255136
31 Dec 224,187618264139
30 Sep 224,058616267138
30 Jun 224,040612255137
31 Mar 223,991588283133
31 Dec 213,875591241136
30 Sep 213,921620139137
30 Jun 213,703603165144
31 Mar 213,592585185143
31 Dec 203,427564241134
30 Sep 203,147532348121
30 Jun 203,093503366121
31 Mar 203,042484361127
31 Dec 192,992459364127
30 Sep 192,821437348127
30 Jun 192,720409352106
31 Mar 192,65138636890
31 Dec 182,58535833780
30 Sep 182,54632635377
30 Jun 182,481298304113
31 Mar 182,40028129791
31 Dec 172,33026330873
30 Sep 172,31425932454
30 Jun 172,2362363460
31 Mar 172,1812163300
31 Dec 162,0571903330
30 Sep 161,8601623060
30 Jun 161,8011592910
31 Mar 161,7581522860
31 Dec 151,7231452800
30 Sep 151,7711412700
30 Jun 151,7711302750
31 Mar 151,7171272520
31 Dec 141,6911252340
30 Sep 141,6531172250
30 Jun 141,5991222160
31 Mar 141,5771212100
31 Dec 131,5451222090

Guadagni di qualità: 600529 has high quality earnings.

Margine di profitto in crescita: 600529's current net profit margins (17.2%) are higher than last year (15.1%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: 600529's earnings have grown by 12.3% per year over the past 5 years.

Accelerare la crescita: 600529's earnings growth over the past year (19.6%) exceeds its 5-year average (12.3% per year).

Guadagni vs Settore: 600529 earnings growth over the past year (19.6%) exceeded the Medical Equipment industry -8.8%.


Rendimento del capitale proprio

ROE elevato: 600529's Return on Equity (11.3%) is considered low.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate